nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—CYP1A2—Progesterone—uterine cancer	0.155	0.186	CbGbCtD
Ergotamine—ABCB1—Progesterone—uterine cancer	0.136	0.162	CbGbCtD
Ergotamine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.123	0.147	CbGbCtD
Ergotamine—ABCB1—Dactinomycin—uterine cancer	0.108	0.129	CbGbCtD
Ergotamine—CYP3A4—Progesterone—uterine cancer	0.0813	0.0973	CbGbCtD
Ergotamine—CYP1A2—Etoposide—uterine cancer	0.0694	0.0831	CbGbCtD
Ergotamine—ABCB1—Etoposide—uterine cancer	0.0607	0.0727	CbGbCtD
Ergotamine—ABCB1—Doxorubicin—uterine cancer	0.0414	0.0496	CbGbCtD
Ergotamine—CYP3A4—Etoposide—uterine cancer	0.0364	0.0436	CbGbCtD
Ergotamine—CYP3A4—Doxorubicin—uterine cancer	0.0248	0.0297	CbGbCtD
Ergotamine—HTR1E—myometrium—uterine cancer	0.0112	0.0701	CbGeAlD
Ergotamine—HTR1B—artery—uterine cancer	0.011	0.0686	CbGeAlD
Ergotamine—HTR1D—artery—uterine cancer	0.0106	0.0665	CbGeAlD
Ergotamine—HTR1E—female gonad—uterine cancer	0.00596	0.0372	CbGeAlD
Ergotamine—ADRA1D—epithelium—uterine cancer	0.0054	0.0337	CbGeAlD
Ergotamine—HTR2A—artery—uterine cancer	0.00529	0.033	CbGeAlD
Ergotamine—ADRA1B—renal system—uterine cancer	0.00512	0.032	CbGeAlD
Ergotamine—HTR2B—myometrium—uterine cancer	0.00478	0.0299	CbGeAlD
Ergotamine—ADRA1D—female reproductive system—uterine cancer	0.00401	0.025	CbGeAlD
Ergotamine—HTR2B—uterine cervix—uterine cancer	0.00372	0.0232	CbGeAlD
Ergotamine—HTR2B—smooth muscle tissue—uterine cancer	0.00362	0.0226	CbGeAlD
Ergotamine—HTR2B—decidua—uterine cancer	0.00355	0.0221	CbGeAlD
Ergotamine—HTR2B—endometrium—uterine cancer	0.00337	0.021	CbGeAlD
Ergotamine—SLC6A2—decidua—uterine cancer	0.00315	0.0197	CbGeAlD
Ergotamine—HTR1A—renal system—uterine cancer	0.00312	0.0195	CbGeAlD
Ergotamine—HTR2B—uterus—uterine cancer	0.0031	0.0194	CbGeAlD
Ergotamine—ADRA1A—epithelium—uterine cancer	0.0031	0.0194	CbGeAlD
Ergotamine—HTR1B—female reproductive system—uterine cancer	0.0031	0.0193	CbGeAlD
Ergotamine—ADRA2A—myometrium—uterine cancer	0.003	0.0188	CbGeAlD
Ergotamine—HTR1D—female reproductive system—uterine cancer	0.003	0.0187	CbGeAlD
Ergotamine—HTR2C—female reproductive system—uterine cancer	0.00297	0.0185	CbGeAlD
Ergotamine—ADRA1A—renal system—uterine cancer	0.00288	0.018	CbGeAlD
Ergotamine—HTR2B—female reproductive system—uterine cancer	0.00279	0.0174	CbGeAlD
Ergotamine—HTR2B—vagina—uterine cancer	0.00252	0.0157	CbGeAlD
Ergotamine—SLC6A2—female reproductive system—uterine cancer	0.00248	0.0155	CbGeAlD
Ergotamine—CYP1A2—renal system—uterine cancer	0.00238	0.0148	CbGeAlD
Ergotamine—ADRA2A—uterine cervix—uterine cancer	0.00234	0.0146	CbGeAlD
Ergotamine—ADRA2A—decidua—uterine cancer	0.00223	0.0139	CbGeAlD
Ergotamine—ADRA2A—endometrium—uterine cancer	0.00211	0.0132	CbGeAlD
Ergotamine—ADRA2A—mammalian vulva—uterine cancer	0.00204	0.0128	CbGeAlD
Ergotamine—HTR2A—epithelium—uterine cancer	0.002	0.0125	CbGeAlD
Ergotamine—ADRA2A—uterus—uterine cancer	0.00195	0.0122	CbGeAlD
Ergotamine—HTR2A—smooth muscle tissue—uterine cancer	0.00193	0.0121	CbGeAlD
Ergotamine—HTR2A—renal system—uterine cancer	0.00186	0.0116	CbGeAlD
Ergotamine—ADRA2A—female reproductive system—uterine cancer	0.00175	0.0109	CbGeAlD
Ergotamine—CYP3A4—renal system—uterine cancer	0.00172	0.0107	CbGeAlD
Ergotamine—ABCB1—myometrium—uterine cancer	0.00167	0.0105	CbGeAlD
Ergotamine—HTR2B—lymph node—uterine cancer	0.00163	0.0102	CbGeAlD
Ergotamine—ADRA2A—female gonad—uterine cancer	0.00159	0.00995	CbGeAlD
Ergotamine—ADRA2A—vagina—uterine cancer	0.00158	0.00989	CbGeAlD
Ergotamine—HTR2A—female reproductive system—uterine cancer	0.00149	0.0093	CbGeAlD
Ergotamine—SLC6A2—lymph node—uterine cancer	0.00145	0.00905	CbGeAlD
Ergotamine—CYP3A4—female reproductive system—uterine cancer	0.00138	0.00861	CbGeAlD
Ergotamine—HTR2A—vagina—uterine cancer	0.00135	0.00841	CbGeAlD
Ergotamine—ABCB1—epithelium—uterine cancer	0.00131	0.0082	CbGeAlD
Ergotamine—ABCB1—uterine cervix—uterine cancer	0.0013	0.00813	CbGeAlD
Ergotamine—ABCB1—decidua—uterine cancer	0.00124	0.00775	CbGeAlD
Ergotamine—ABCB1—renal system—uterine cancer	0.00122	0.00761	CbGeAlD
Ergotamine—ABCB1—endometrium—uterine cancer	0.00118	0.00736	CbGeAlD
Ergotamine—ABCB1—mammalian vulva—uterine cancer	0.00114	0.00711	CbGeAlD
Ergotamine—ABCB1—uterus—uterine cancer	0.00109	0.00678	CbGeAlD
Ergotamine—ADRA2A—lymph node—uterine cancer	0.00102	0.0064	CbGeAlD
Ergotamine—ABCB1—female reproductive system—uterine cancer	0.000976	0.00609	CbGeAlD
Ergotamine—ABCB1—female gonad—uterine cancer	0.000888	0.00554	CbGeAlD
Ergotamine—ABCB1—vagina—uterine cancer	0.000882	0.00551	CbGeAlD
Ergotamine—ABCB1—lymph node—uterine cancer	0.000571	0.00356	CbGeAlD
Ergotamine—Cyanosis—Etoposide—uterine cancer	0.000241	0.0514	CcSEcCtD
Ergotamine—Numbness—Etoposide—uterine cancer	0.000206	0.0438	CcSEcCtD
Ergotamine—Sensory loss—Etoposide—uterine cancer	0.000197	0.042	CcSEcCtD
Ergotamine—Pain—Carboplatin—uterine cancer	0.000194	0.0413	CcSEcCtD
Ergotamine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.000155	0.0329	CcSEcCtD
Ergotamine—Vertigo—Progesterone—uterine cancer	0.000131	0.0279	CcSEcCtD
Ergotamine—Hypertension—Progesterone—uterine cancer	0.000126	0.0268	CcSEcCtD
Ergotamine—Myalgia—Progesterone—uterine cancer	0.000124	0.0264	CcSEcCtD
Ergotamine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000119	0.0253	CcSEcCtD
Ergotamine—Tachycardia—Progesterone—uterine cancer	0.000116	0.0247	CcSEcCtD
Ergotamine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000113	0.024	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000109	0.0231	CcSEcCtD
Ergotamine—Paraesthesia—Progesterone—uterine cancer	0.000107	0.0228	CcSEcCtD
Ergotamine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000105	0.0224	CcSEcCtD
Ergotamine—Pain—Progesterone—uterine cancer	0.000102	0.0217	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	9.84e-05	0.0209	CcSEcCtD
Ergotamine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	9.7e-05	0.0206	CcSEcCtD
Ergotamine—Myalgia—Dactinomycin—uterine cancer	8.79e-05	0.0187	CcSEcCtD
Ergotamine—Asthenia—Progesterone—uterine cancer	8.55e-05	0.0182	CcSEcCtD
Ergotamine—Hypoaesthesia—Etoposide—uterine cancer	8.54e-05	0.0182	CcSEcCtD
Ergotamine—Pruritus—Progesterone—uterine cancer	8.43e-05	0.0179	CcSEcCtD
Ergotamine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	7.75e-05	0.0165	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	7.67e-05	0.0163	CcSEcCtD
Ergotamine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	7.64e-05	0.0163	CcSEcCtD
Ergotamine—Vomiting—Progesterone—uterine cancer	7.58e-05	0.0161	CcSEcCtD
Ergotamine—Pain—Dactinomycin—uterine cancer	7.2e-05	0.0153	CcSEcCtD
Ergotamine—Nausea—Progesterone—uterine cancer	7.08e-05	0.0151	CcSEcCtD
Ergotamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	6.87e-05	0.0146	CcSEcCtD
Ergotamine—Vertigo—Etoposide—uterine cancer	6.71e-05	0.0143	CcSEcCtD
Ergotamine—Hypertension—Etoposide—uterine cancer	6.45e-05	0.0137	CcSEcCtD
Ergotamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	6.41e-05	0.0136	CcSEcCtD
Ergotamine—Asthenia—Dactinomycin—uterine cancer	6.04e-05	0.0129	CcSEcCtD
Ergotamine—Tachycardia—Etoposide—uterine cancer	5.95e-05	0.0127	CcSEcCtD
Ergotamine—Paraesthesia—Etoposide—uterine cancer	5.47e-05	0.0116	CcSEcCtD
Ergotamine—Vomiting—Dactinomycin—uterine cancer	5.36e-05	0.0114	CcSEcCtD
Ergotamine—Pain—Etoposide—uterine cancer	5.21e-05	0.0111	CcSEcCtD
Ergotamine—Nausea—Dactinomycin—uterine cancer	5e-05	0.0106	CcSEcCtD
Ergotamine—Bradycardia—Epirubicin—uterine cancer	4.9e-05	0.0104	CcSEcCtD
Ergotamine—Hypoaesthesia—Epirubicin—uterine cancer	4.79e-05	0.0102	CcSEcCtD
Ergotamine—Bradycardia—Doxorubicin—uterine cancer	4.53e-05	0.00964	CcSEcCtD
Ergotamine—Hypoaesthesia—Doxorubicin—uterine cancer	4.43e-05	0.00942	CcSEcCtD
Ergotamine—Asthenia—Etoposide—uterine cancer	4.37e-05	0.0093	CcSEcCtD
Ergotamine—Pruritus—Etoposide—uterine cancer	4.31e-05	0.00917	CcSEcCtD
Ergotamine—Vomiting—Etoposide—uterine cancer	3.88e-05	0.00825	CcSEcCtD
Ergotamine—Vertigo—Epirubicin—uterine cancer	3.76e-05	0.008	CcSEcCtD
Ergotamine—Nausea—Etoposide—uterine cancer	3.62e-05	0.0077	CcSEcCtD
Ergotamine—Hypertension—Epirubicin—uterine cancer	3.61e-05	0.00769	CcSEcCtD
Ergotamine—Myalgia—Epirubicin—uterine cancer	3.56e-05	0.00758	CcSEcCtD
Ergotamine—Vertigo—Doxorubicin—uterine cancer	3.48e-05	0.0074	CcSEcCtD
Ergotamine—Hypertension—Doxorubicin—uterine cancer	3.34e-05	0.00712	CcSEcCtD
Ergotamine—Tachycardia—Epirubicin—uterine cancer	3.33e-05	0.00709	CcSEcCtD
Ergotamine—Myalgia—Doxorubicin—uterine cancer	3.3e-05	0.00702	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Epirubicin—uterine cancer	3.11e-05	0.00662	CcSEcCtD
Ergotamine—Tachycardia—Doxorubicin—uterine cancer	3.09e-05	0.00656	CcSEcCtD
Ergotamine—Paraesthesia—Epirubicin—uterine cancer	3.07e-05	0.00653	CcSEcCtD
Ergotamine—Pain—Epirubicin—uterine cancer	2.92e-05	0.00622	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	2.88e-05	0.00613	CcSEcCtD
Ergotamine—Paraesthesia—Doxorubicin—uterine cancer	2.84e-05	0.00604	CcSEcCtD
Ergotamine—Pain—Doxorubicin—uterine cancer	2.7e-05	0.00575	CcSEcCtD
Ergotamine—Asthenia—Epirubicin—uterine cancer	2.45e-05	0.00522	CcSEcCtD
Ergotamine—Pruritus—Epirubicin—uterine cancer	2.42e-05	0.00514	CcSEcCtD
Ergotamine—Asthenia—Doxorubicin—uterine cancer	2.27e-05	0.00483	CcSEcCtD
Ergotamine—Pruritus—Doxorubicin—uterine cancer	2.24e-05	0.00476	CcSEcCtD
Ergotamine—Vomiting—Epirubicin—uterine cancer	2.17e-05	0.00462	CcSEcCtD
Ergotamine—Nausea—Epirubicin—uterine cancer	2.03e-05	0.00432	CcSEcCtD
Ergotamine—Vomiting—Doxorubicin—uterine cancer	2.01e-05	0.00428	CcSEcCtD
Ergotamine—Nausea—Doxorubicin—uterine cancer	1.88e-05	0.004	CcSEcCtD
